TrialJournal of neuro-oncology2017

A phase II trial of arsenic trioxide and temozolomide in combination with radiation therapy for patients with malignant gliomas.

Priya Kumthekar et al.PubMed ↗Publisher ↗

No numbers read from the abstract.